Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.
Pouget M, Abrial C, Planchat E, Van Praagh I, Arbre M, Kwiatkowski F, Dubray-Longeras P, Devaud H, Dohou J, Herviou P, Mahammedi H, Durando X, Chollet P, Mouret-Reynier MA. Pouget M, et al. Among authors: planchat e. Oncology. 2015;89(6):319-31. doi: 10.1159/000437230. Epub 2015 Oct 13. Oncology. 2015. PMID: 26457979
The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study.
Mahammedi H, Planchat E, Pouget M, Durando X, Curé H, Guy L, Van-Praagh I, Savareux L, Atger M, Bayet-Robert M, Gadea E, Abrial C, Thivat E, Chollet P, Eymard JC. Mahammedi H, et al. Among authors: planchat e. Oncology. 2016;90(2):69-78. doi: 10.1159/000441148. Epub 2016 Jan 16. Oncology. 2016. PMID: 26771576 Clinical Trial.
Prognostic value of initial tumor parameters after metastatic relapse.
Planchat E, Durando X, Abrial C, Thivat E, Mouret-Reynier MA, Ferrière JP, Pomel C, Kwiatkowski F, Chollet P, Nabholtz JM. Planchat E, et al. Cancer Invest. 2011 Nov;29(9):635-43. doi: 10.3109/07357907.2011.621911. Cancer Invest. 2011. PMID: 22011286
Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?
Gilliot O, Durando X, Abrial C, Bellière A, Gimbergues P, Thivat E, Planchat E, Lapeyre M, Kwiatkowski F, Toledano I, Chollet P, Nabholtz JM, Verrelle P. Gilliot O, et al. Among authors: planchat e. Cancer Invest. 2010 Feb;28(2):195-200. doi: 10.3109/07357900903179658. Cancer Invest. 2010. PMID: 19968496
Temozolomide and unusual indications: review of literature.
Tatar Z, Thivat E, Planchat E, Gimbergues P, Gadea E, Abrial C, Durando X. Tatar Z, et al. Among authors: planchat e. Cancer Treat Rev. 2013 Apr;39(2):125-35. doi: 10.1016/j.ctrv.2012.06.002. Epub 2012 Jul 19. Cancer Treat Rev. 2013. PMID: 22818211 Review.
Long-term significance (15 years) of pathological complete response after dose-dense neoadjuvant chemotherapy in breast cancer.
Wang-Lopez Q, Abrial C, Planchat E, Mouret-Reynier MA, Cure H, Gimbergues P, Dubray-Longeras P, Gadea E, Kwiatkowski F, Penault-Llorca F, Chollet P, Durando X. Wang-Lopez Q, et al. Among authors: planchat e. Breast J. 2013 Jul-Aug;19(4):448-50. doi: 10.1111/tbj.12131. Epub 2013 Jun 11. Breast J. 2013. PMID: 23750595 No abstract available.
11 results